Oral surgery, oral medicine, oral pathology and oral radiology · 2013
Ultrasound evaluation of masseter muscle changes in stabilization splint treatment of myofascial type painful temporomandibular diseases.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Aldemir Korkut, Üstüner Evren, Erdem Erdal, Demiralp A Samimi, Oztuna Derya
Аннотация
OBJECTIVES: To detect whether stabilization splint (SS) treatment of painful myofascial type temporomandibular diseases (TMD) changes the masseter muscle morphology using ultrasound (US).
STUDY DESIGN: Thirty-five patients with painful myofascial TMD receiving SS treatment were studied. Masseter thickness, length, internal echo-fibrillary structure and vascularization were evaluated using gray-scale and power Doppler US just before and 3 months after the SS application. Visual analog scale (VAS) and mouth opening measurements were used to measure the outcome of treatment.
RESULTS: A significant shortening in the masseter muscle length (R: -3.67 mm, P: .010; L: -3.97 mm, P: .005) and thickness (R: -0.93 mm, P: .005; L: -0.90 mm, P: .016) was noted. No change in the internal echo-fibrillary structure or vascularization was detected. A significant decrease in VAS scores (Median: 5-0.5 P < .05) and mouth opening (42.77 ± 7.86 mm to 38.69 ± 6.21, P < .05) was also detected.
CONCLUSION: SSs modify and reduce the dimensions of masseter muscle.
STUDY DESIGN: Thirty-five patients with painful myofascial TMD receiving SS treatment were studied. Masseter thickness, length, internal echo-fibrillary structure and vascularization were evaluated using gray-scale and power Doppler US just before and 3 months after the SS application. Visual analog scale (VAS) and mouth opening measurements were used to measure the outcome of treatment.
RESULTS: A significant shortening in the masseter muscle length (R: -3.67 mm, P: .010; L: -3.97 mm, P: .005) and thickness (R: -0.93 mm, P: .005; L: -0.90 mm, P: .016) was noted. No change in the internal echo-fibrillary structure or vascularization was detected. A significant decrease in VAS scores (Median: 5-0.5 P < .05) and mouth opening (42.77 ± 7.86 mm to 38.69 ± 6.21, P < .05) was also detected.
CONCLUSION: SSs modify and reduce the dimensions of masseter muscle.